
Gilead Sciences is preparing to lay off around a fifth of its salesforce in anticipation for the expiry of patents …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

